Document is current
Any future updates will be listed below
-
Authors
Bongiovanni, Marco
Thoueille, Paul
Barda, Beatrice
Mercier, Thomas
Marzolini, Catia
Ramponi, Niccolò
Choong, Eva
Cantù, Marco
Decosterd, Laurent A.
Bernasconi, Enos
- License Information
-
More Information
Article History
Received: 29 February 2024
Accepted: 3 May 2024
First Online: 14 May 2024
Declarations
:
: The authors declare no competing interests.
: LAD have received from Menarini GmbH (that markets Oritavancin) an honorary for Advisory Board Meetings, a Research Grant for the setting-up of TDM of oritavancin and a Service Contract for oritavancin analyses in patients samples.All other authors: None to declare.
